Prion protein interactions with nucleic acid: Possible models for prion disease and prion function

被引:18
|
作者
Grossman, A
Zeiler, B
Sapirstein, V
机构
[1] Q RNA Inc, New York, NY 10032 USA
[2] SerOptix Inc, Woburn, MA 01801 USA
关键词
BSE; RNA; PrP; RNA-protein interactions; DNA-protein interactions;
D O I
10.1023/A:1023215207981
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Several models for the transmission and progression of prion diseases have arisen, evolving with the acquisition of new experimental results. It is generally accepted that the PrPSc protein is at least part of the infectious particle and the major protein component of the scrapie-associated fibrils (SAFs) that characterize the disease. An additional, unknown cofactor is most likely involved in transmission of the disease, perhaps by influencing the PrPC PrPSc transition. This review relates experimental observations on the interactions of nucleic acids (NAs) and PrP with specific focus on alterations in structure. In particular, NAs appear to induce PrPC to acquire some of the structural and biochemical characteristics of PrPSc. An updated hypothesis is related wherein NAs, on the basis of their structure, act in the PrPC PrPSc transformation by serving as catalysts and/or chaperones and not by encoding genetic information.
引用
收藏
页码:955 / 963
页数:9
相关论文
共 50 条
  • [21] Prion protein self-peptides modulate prion interactions and conversion
    Rigter, Alan
    Priem, Jan
    Timmers-Parohi, Drophatie
    Langeveld, Jan P. M.
    van Zijderveld, Fred G.
    Bossers, Alex
    BMC BIOCHEMISTRY, 2009, 10
  • [22] The Elusive Role of the Prion Protein and the Mechanism of Toxicity in Prion Disease
    Chiesa, Roberto
    PLOS PATHOGENS, 2015, 11 (05)
  • [23] Prion disease:: soluble dimeric prion protein binds PrPSc
    Genoud, N
    M S-MEDECINE SCIENCES, 2003, 19 (12): : 1195 - 1196
  • [24] The function of the cellular prion protein in health and disease
    Watts, Joel C.
    Bourkas, Matthew E. C.
    Arshad, Hamza
    ACTA NEUROPATHOLOGICA, 2018, 135 (02) : 159 - 178
  • [25] Vessel wall prion protein immunoreactivity in human prion disease
    Koperek, O
    Kovács, GG
    Budka, H
    Wick, G
    ACTA NEUROPATHOLOGICA, 2001, 102 (05) : 530 - 530
  • [26] Aberrant metal binding by prion protein in human prion disease
    Wong, BS
    Chen, SG
    Colucci, M
    Xie, ZL
    Pan, T
    Liu, T
    Li, RL
    Gambetti, P
    Sy, MS
    Brown, DR
    JOURNAL OF NEUROCHEMISTRY, 2001, 78 (06) : 1400 - 1408
  • [27] Polymerization of murine recombinant prion protein in nucleic acid solution
    P. K. Nandi
    E. Leclerc
    Archives of Virology, 1999, 144 : 1751 - 1763
  • [28] The hypothesis of the catalytic action of nucleic acid on the conversion of prion protein
    Cordeiro, Y
    Silva, JL
    PROTEIN AND PEPTIDE LETTERS, 2005, 12 (03): : 251 - 255
  • [29] Polymerization of murine recombinant prion protein in nucleic acid solution
    Nandi, PK
    Leclerc, E
    ARCHIVES OF VIROLOGY, 1999, 144 (09) : 1751 - 1763
  • [30] Structural insights into the interaction between prion protein and nucleic acid
    Trambaioli da Rocha e Lima, Luis Mauricio
    Cordeiro, Yraima
    Tinoco, Luzineide W.
    Marques, Adriana F.
    Oliveira, Cristiano L. P.
    Sampath, Srisailam
    Kodali, Ravindra
    Choi, Gildon
    Foguel, Debora
    Torriani, Iris
    Caughey, Byron
    Silva, Jerson L.
    BIOCHEMISTRY, 2006, 45 (30) : 9180 - 9187